Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12916-015-0446-9
DC FieldValue
dc.titleThe broader economic impact of vaccination: Reviewing and appraising the strength of evidence
dc.contributor.authorJit M.
dc.contributor.authorHutubessy R.
dc.contributor.authorPng M.E.
dc.contributor.authorSundaram N.
dc.contributor.authorAudimulam J.
dc.contributor.authorSalim S.
dc.contributor.authorYoong J.
dc.date.accessioned2020-09-03T10:33:42Z
dc.date.available2020-09-03T10:33:42Z
dc.date.issued2015
dc.identifier.citationJit M., Hutubessy R., Png M.E., Sundaram N., Audimulam J., Salim S., Yoong J. (2015). The broader economic impact of vaccination: Reviewing and appraising the strength of evidence. BMC Medicine 13 (1) : 209. ScholarBank@NUS Repository. https://doi.org/10.1186/s12916-015-0446-9
dc.identifier.issn17417015
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174120
dc.description.abstractBackground: Microeconomic evaluations of public health programmes such as immunisation typically only consider direct health benefits and medical cost savings. Broader economic benefits around childhood development, household behaviour, and macro-economic indicators are increasingly important, but the evidence linking immunization to such benefits is unclear. Methods: A conceptual framework of pathways between immunisation and its proposed broader economic benefits was developed through expert consultation. Relevant articles were obtained from previous reviews, snowballing, and expert consultation. Articles were associated with one of the pathways and quality assessed using modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Results: We found 20 studies directly relevant to one or more pathways. Evidence of moderate quality from experimental and observational studies was found for benefits due to immunisation in improved childhood physical development, educational outcomes, and equity in distribution of health gains. Only modelling evidence or evidence outside the immunization field supports extrapolating these benefits to household economic behaviour and macro-economic indicators. Conclusion: Innovative use of experimental and observational study designs is needed to fill evidence gaps around key pathways between immunisation and many of its proposed economic benefits. © 2015 Jit et al.
dc.sourceUnpaywall 20200831
dc.subjectvaccine
dc.subjectArticle
dc.subjectbudget
dc.subjectchild development
dc.subjectconceptual framework
dc.subjectcost control
dc.subjectcost effectiveness analysis
dc.subjecteconomic aspect
dc.subjecteconomic evaluation
dc.subjecteducational status
dc.subjectevidence based medicine
dc.subjecthealth program
dc.subjecthuman
dc.subjectmedical decision making
dc.subjectphysical development
dc.subjectvaccination
dc.subjectcost benefit analysis
dc.subjecteconomics
dc.subjectvaccination
dc.subjectCost-Benefit Analysis
dc.subjectHumans
dc.subjectVaccination
dc.typeArticle
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.description.doi10.1186/s12916-015-0446-9
dc.description.sourcetitleBMC Medicine
dc.description.volume13
dc.description.issue1
dc.description.page209
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s12916-015-0446-9.pdf916.1 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.